相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
Kevin B. Boylan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Markus Otto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Amyloid precursor protein (APP) contributes to pathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis
J. Barney Bryson et al.
HUMAN MOLECULAR GENETICS (2012)
CSF markers in amyotrophic lateral sclerosis
Joanna Tarasiuk et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic
Nils von Neuhoff et al.
PLOS ONE (2012)
β-Amyloid triggers ALS-associated TDP-43 pathology in AD models
Alexander M. Herman et al.
BRAIN RESEARCH (2011)
Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS
Jeban Ganesalingam et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
Robert Bowser et al.
NATURE REVIEWS NEUROLOGY (2011)
Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration
Thomas Philips et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'
C. E. Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
DISCOVERY AND VERIFICATION OF AMYOTROPHIC LATERAL SCLEROSIS BIOMARKERS BY PROTEOMICS
Henrik Ryberg et al.
MUSCLE & NERVE (2010)
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse
I. Taes et al.
NEUROLOGY (2010)
CSF glial markers correlate with survival in amyotrophic lateral sclerosis
S. D. Suessmuth et al.
NEUROLOGY (2010)
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
Helene Blasco et al.
PLOS ONE (2010)
Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
Meghan E. Wilson et al.
PLOS ONE (2010)
Serum Biomarker for Progranulin-Associated Frontotemporal Lobar Degeneration
Kristel Sleegers et al.
ANNALS OF NEUROLOGY (2009)
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
NiCole Finch et al.
BRAIN (2009)
Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis
P. Paladino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis
Eun Jin Yoon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Petra Steinacker et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Decreased Cystatin C Immunoreactivity in Spinal Motor Neurons and Astrocytes in Amyotrophic Lateral Sclerosis
Fumiaki Mori et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Progranulin (PGRN) expression in ALS: An immunohistochemical study
D. Irwin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease
Miryam Carecchio et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
LANCET NEUROLOGY (2009)
Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide
Luisa Benussi et al.
NEUROBIOLOGY OF DISEASE (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Mutations in progranulin gene:: Clinical, pathological, and ribonucleic acid expression findings
Adolofo Lopez de Munain et al.
BIOLOGICAL PSYCHIATRY (2008)
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Koji Yamanaka et al.
NATURE NEUROSCIENCE (2008)
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
R. Ghidoni et al.
NEUROLOGY (2008)
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients
Tetsuya Nagata et al.
NEUROLOGICAL RESEARCH (2007)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
Onset and progression in inherited ALS determined by motor neurons and microglia
Severine Boillee et al.
SCIENCE (2006)
Identification of potential CSF biomarkers in ALS
GM Pasinetti et al.
NEUROLOGY (2006)
Axonal damage markers in cerebrospinal fluid are increased in ALS
J Brettschneider et al.
NEUROLOGY (2006)
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis
S Ranganathan et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis
P Baron et al.
MUSCLE & NERVE (2005)
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
O Carrette et al.
PROTEOMICS (2005)
β-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients
NY Calingasan et al.
NEUROBIOLOGY OF DISEASE (2005)
Amyotrophic lateral sclerosis:: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum
SD Süssmuth et al.
NEUROSCIENCE LETTERS (2003)
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration
H Wilms et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Medical progress: Amyotrophic lateral sclerosis.
LP Rowland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)